| Business Name: |
Rivera-Nieves Jesus MD |
| Contact Person: |
Jesus Rivera-Nieves, |
| Address: |
9500 Gilman Drive # Uc303-218m, La Jolla, California 92093 |
| Phone Number: |
(858) 534-1501 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Harish S Hosalkar MD - La Jolla, CA 92093
Rosenblum Elizabeth MD - La Jolla, CA 92093
Nyhan William MD - La Jolla, CA 92093
Schneider Jerry MD - La Jolla, CA 92093
Nguyen Thao P MD - La Jolla, CA 92093
Ucsd Medical Group - La Jolla, CA 92093
Mittman Charles MD - La Jolla, CA 92093
Lee Susan J MD - La Jolla, CA 92093
Wagner Peter MD - La Jolla, CA 92093
Golomb Beatrice MD - La Jolla, CA 92093
Hostetler Karl Y MD - La Jolla, CA 92093
Kallenberg Gene A MD - La Jolla, CA 92093
Smith Margaret L MD - La Jolla, CA 92093
Lowy Andrew M MD - La Jolla, CA 92093
Witzum Joseph MD - La Jolla, CA 92093
Mendoza Stanley A MD - La Jolla, CA 92093
Bagga Harmohina MD - La Jolla, CA 92093
Carson Dennis A MD - La Jolla, CA 92093
Wiese Cristina MD - La Jolla, CA 92093
Lanouette Nicole MD - La Jolla, CA 92093
|
The company Rivera-Nieves Jesus MD provides B2C services in the form of Doctors from its single location in California.
1 to 4 employees work for Rivera-Nieves Jesus MD, and the business now earns $500.000 to $999.999 per annum.
Rivera-Nieves Jesus MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Rivera-Nieves Jesus MD, please call Jesus Rivera-Nieves, with the phone number (858) 534-1501 or visit its single location at 9500 Gilman Drive # Uc303-218m in La Jolla, California 92093.
The location of the single location can also be found using the coordinates 32.87306,-117.2401.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.